Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Army
Dow
Fuji
Argus Health
Johnson and Johnson
Mallinckrodt
Chinese Patent Office
Boehringer Ingelheim
Colorcon

Generated: January 16, 2018

DrugPatentWatch Database Preview

ISOETHARINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Isoetharine Hydrochloride patents expire, and when can generic versions of Isoetharine Hydrochloride launch?

Isoetharine Hydrochloride is a drug marketed by Alpharma Us Pharms, Astrazeneca, Baxter Hlthcare, DEY, Intl Medication, Parke Davis, and Roxane. and is included in thirty-three NDAs.

The generic ingredient in ISOETHARINE HYDROCHLORIDE is isoetharine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the isoetharine hydrochloride profile page.
Summary for ISOETHARINE HYDROCHLORIDE
Drug patent expirations by year for ISOETHARINE HYDROCHLORIDE

US Patents and Regulatory Information for ISOETHARINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 088226-001 Sep 16, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 085997-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 087324-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 085889-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 087101-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dey ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 088188-001 Dec 3, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Intl Medication ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 086651-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dey ISOETHARINE HYDROCHLORIDE S/F isoetharine hydrochloride SOLUTION;INHALATION 089820-001 Nov 22, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 089616-001 Jun 13, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dey ISOETHARINE HYDROCHLORIDE S/F isoetharine hydrochloride SOLUTION;INHALATION 089817-001 Nov 22, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
Cerilliant
Covington
Chinese Patent Office
McKesson
Queensland Health
Novartis
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot